NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Bed Bath & Beyond (BBBY) was upgraded from Neutral to Outperform at Credit Suisse. $91 price target. Cost Plus acquisition should help boost growth.
Best Buy (BBY) downgraded from Outperform to Neutral at Credit Suisse. Company is facing multiple operating distractions. $20 price target.
The Buckle (BKE) was initiated with an Underperform rating at Bank of America Merrill Lynch. $42 price target. Slowing growth should drive underperformance.Meta Financial Group (CASH) was upgraded to Buy at TheStreet Ratings. Clear Channel Communications (CCO) was downgraded to Sell at TheStreet Ratings. C.H. Robinson Worldwide (CHRW) was rated new Perform at Oppenheimer. Do not anticipate the market bolstering its trading multiple. Heska (HSKA) was upgraded to Buy at TheStreet Ratings. Incyte (INCY) was upgraded to Buy from Neutral at Goldman Sachs. $29 price target. Strong Jakafi launch and pipeline has upside potential. JP Morgan (JPM) was downgraded to Market Perform at FBR Capital Markets. $37 price target. Credit derivative losses are cutting into earnings. Landstar System (LSTR) was rated new Outperform at Oppenheimer said. $66 price target. Revenue and gross profit growth in the double digits. Steinway Musical Instruments (LVB) was upgraded to Buy at TheStreet Ratings. Macerich (MAC) was downgraded to Hold from Buy at Jefferies. Still like the story but upside now seems limited. Myriad Genetics (MYGN) was initiated with a Neutral rating at Bank of America Merrill Lynch. $28 price target. Shares appear fairly valued given uncertainties. PSS World Medical (PSSI) was downgraded from Outperform to Neutral at Robert Baird. $21 price target. Company missed expectations again and lacks near-term catalysts. Rexnord (RXN) was initiated with a Neutral rating at Goldman Sachs. Valuation call, based on a $23 price target. AT&T (T) was upgraded to Outperform at Credit Suisse said. Spending discipline appears to be improving across the industry. $36.50 price target. Verizon (VZ) was upgraded to Outperform at Credit Suisse. $45 price target. Estimates also boosted, given higher expected wireless margins. Zumiez (ZUMZ) was initiated with a Buy rating, Bank of America Merrill Lynch said. $44 price target. e-commerce, young stores, and share gains should fuel growth. Wynn Resorts (WYNN) was downgraded to Hold at TheStreet Ratings.
STOCK COMMENTS / EPS CHANGESApple (AAPL) estimates were cut through 2013 at Credit Suisse. Expect slower U.S. smartphone growth. Outperform rating and $750 price target. Sotheby's (BID) estimates, target cut at Craig-Hallum. Shares of BID now seen reaching $40, according to Craig-Hallum. Estimates also reduced, as the company is realizing lower margins. Buy rating. Express Scripts (ESRX) estimates lowered through 2013 at Citigroup. Strong results, but tweak EPS for taxes and shares. Buy rating and $66 price target. Federal Realty Investment Trust (FRT) numbers raised at Jefferies. Shares of FRT now seen reaching $103, Jefferies said. Estimates also raised on operating results that should continue to improve. Hold rating. Joy Global (JOY) target lowered at Jefferies. Shares of JOY now seen reaching $74, Jefferies said. Lower aftermarket sales. Hold rating. JP Morgan (JPM) estimates lowered through 2012 on current trading loss estimate at Citigroup. Buy rating and $54 price target. Molycorp (MCP) estimates, target cut at JP Morgan. Shares of MCP now seen reaching $23, according to JP Morgan. Estimates also reduced, given lower expected rare earth prices. Neutral rating. Qualcomm (QCOM) estimates were cut through 2013 at Credit Suisse. Expect fewer smartphone subsidies, which could cut into U.S. sales. Outperform rating and $75 price target. Research in Motion (RIMM) estimates were reduced through 2014 at Credit Suisse. Expect slower domestic smartphone growth. Neutral rating and $14.50 price target. Roundy's (RNDY) numbers lowered at Jefferies. Shares of RNDY now seen reaching $13, Jefferies said. Estimates also lowered on a tough year for the food-at-home vertical. Buy rating. Safeway (SWY) estimates were cut through 2014 at Morgan Stanley. Don't expect sales volumes to improve in the near term. Equal-weight rating. >To submit a news tip, email: firstname.lastname@example.org.
Follow TheStreet on Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV